Diagnostic importance and pitfalls of evaluating bone marrow smear preparation in multiple myeloma;Diagnostický význam a úskalí hodnocení roztěrového preparátu kostní dřeně u mnohočetného myelomu

Vnitrni Lekarstvi

Volumn 52, Issue SUPPL. 2, 2006, Pages 55-65

  Ščudla, Vlastimil ^a   Adam, Z ^b  

^a PALACKÝ UNIVERSITY   (Czech Republic)

^b UNIVERSITY HOSPITAL BRNO   (Czech Republic)

Author keywords

Bone marrow biopsy; Course evaluation; Diagnosis; Differential diagnosis; Morphological classification of myeloma; Morphology of myeloma plasmocytes; Multiple myeloma; Plasmatic cells

Indexed keywords

APOPTOSIS; ASPIRATION BIOPSY; BONE MARROW BIOPSY; CANCER CLASSIFICATION; CANCER DIAGNOSIS; CANCER SCREENING; HUMAN; IMMUNOPHENOTYPING; MONITORING; MONOCLONAL IMMUNOGLOBULINEMIA; MULTIPLE MYELOMA; PLASMACYTOSIS; PROGNOSIS; REVIEW; SMEAR;

BIOPSY, NEEDLE; BONE MARROW; BONE MARROW EXAMINATION; CYTODIAGNOSIS; DIAGNOSIS, DIFFERENTIAL; HUMANS; MULTIPLE MYELOMA;

EID: 33751567451     PISSN: 0042773X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (38)

1. Kyle RA, Child JA, Durie BGM et al. Criteria for the classification of monoclonal gammopathies, multiple myeloma, and related disorders: a report of the International Myeloma Working Group. Brit J Haematol 2003; 121: 749-757.
2. Adam Z, Ščudla V, Neubauer J. Mnohočetný myelom. In: Adam Z, Vorlíček J et al. Hematologie II. Přehled malignich hematologických nemocí. Praha: Grada Publishing 2001: 461-502.
3. Adam Z et al. Diagnostika a léčba mnohočetné ho myelomu. Doporučení vypracované Českou myelomovou skupinou, Myelomovou sekcí ČHS a experty Slovenské republiky pro diagnostiku a léčbu mnohočetného myelomu. Vnitř Lék 2005; 51(Suppl 1): 3-51.
4. Scudla V, Ordeltova M, Minarik J et al. Prognostic significance of plasma cell propidium iodide and annexin-V indices and their mutual ratio in multiple myeloma. Neoplasma 2006; 53: 213-218.
5. Scudla V, Ordeltova M, Bacovsky J et al. The relationship between proliferation and apoptosis in patients with monoclonal gammopathy of undetermined significance or multiple myeloma. Hematologica 2005; 90: 1713-1714.
6. SWOG Southwest Oncology Group. Remission maintenance therapy for multiple myeloma. Arch Int Med 1975; 135: 147-152.
7. Kyle RA, Bayrd ED. The monoclonal gammopathies. Multiple myeloma and related plasma-cell disorders. Springfield: Charles Thomas Publisher 1976.
8. Sakalová A et al. Generalizovaný plazmocytóm. Bratislava: Veda 1983.
9. Frisch B, Bartl R. Biopsy interpretation of bone and bone marrow. London: Arnold 1999.
10. Špička I et al. Mnohočetný myelom a další monoklonální gamapatie. Praha: Galén 2005.
11. Bartl R, Frisch B, Burkhardt G et al. Bone marrow histology in myeloma: its importance in diagnosis, prognosis, classification and staging. Brit J Haematol 1982; 51: 361-375.
12. Grogan TM, Gelbspan D, Rimsza L. Hematologic investigations: morphologic and phenotypic features of myeloma marrow diagnosis. In: Gahrton G, Durie BGM, Samson DM. Multiple myeloma and related disorders. London: Arnold 2004: 102-124.
13. Bartl R, Frisch B, Wilmanns W. Morphology of multiple myeloma. In: Malpas JS, Bergsagel DE, Kyle RA. Myeloma biology and management. Oxford: Oxford medical publications 1995: 83-123.
14. Pour L, Penka M, Smolej L et al. Hodnocení kostní dfřně u pacìentů s mnohočetným myelomem v různých fázích odběru. Hemat Transf 2006; v tisku.
15. Dispenzieri A, Lacy MQ, Greipp PR. Multiple myeloma. In: Greer JP, Foerster J, Lukens JN et al. Wintrobe's clinical hematology. 11th ed. Philadelphia: Lippincott Williams & Wilkins 2004: 2583-2636.
16. Hoffbrand AV, Pettit JE. Sandoz atlas of clinical hematology. 2nd ed. Barcelona: Mosby-Wolfe 1994.
17. Campr V. Morfologické rysy mnohočetného myelomu. In: Špička I et al. Mnohočetný myelom a další monoklonální gamapatie. Praha: Galén 2005: 44-46.
18. Farquhar MG, Palade GE. The Golgi apparatus (1954-1981) from artifact to center stage. J Cell Biol 1981; 91(Suppl): 77-103.
19. Hobbs JR. The immunoglobulins and their abnormalities. In: Hardisty RM, Weatherall DJ. Blood and its disorders. Oxford: Blackwell Scientific Publications 1974: 1319-1373.
20. Drivsholm A, Clausen J. The relationship between the cytology and immunoelectrophoretic pattern in 105 cases of myelomatosis. Acta Med Scand 1964; 175: 609-620.
21. Gaja A, Buliková A, Novotný J et al. Plazmocytom s fagocytární aktivitou. Trans Hemat 2004; 10: 76-77.
22. Blade J, Samson D, Reece D et al. Criteria for evaluating disease response and progression in patients with multiple myeloma treated by high-dose therapy and haematopoietic stem cell transplantation. Brit J Haematol 1998; 102: 1115-1123.
23. Wutke K, Varbiro M, Rdiger G et al. Cytological and histological classification of multiple myeloma. Haematologia 1981; 14: 315-329.
24. Cardozo PL. Atlas of clinical cytology. Herhogenbasch: Targa e.v.s 1975, ISBN 90-90000-16.
25. Greipp PR, Leong T, Bennett JM et al. Plasmoblastic morphology - an independent prognostic factor with clinical and laboratory correlates: Eastern Cooperative Oncology Group (ECOG) myeloma trial E9486 report by the ECOG Myeloma laboratory group. Blood 1998; 91: 2501-2507.
26. Greipp PR, Raymond NM, Kyle RA. Multiple myeloma: significance of plasmoblastic subtype in morphologic classification. Blood 1985; 65: 305-310.
27. Rajkumar SV, Fonseca R, Lacy MQ et al. Plasmoblastic morphology is an independent predictor for poor survival following autologous stem-cell transplantation for multiple myeloma. J Clin Oncol 1999; 17: 1551-1557.
28. Rajkumar SV, Fonseca R, Díspenzieri A et al. Methods for estimation of bone marrow plasma cell involvement in myeloma: predictive value for response and survival in patients undergoing autologous stem cell transplantation. Am J Hematol 2001; 68: 269-275.
29. Barlogie B, Shaughnessy J, Munshi N et al. Plasma cell myeloma. In: Beutler E, Lichtman MA, Coller BS et al. Williams hematology. 6th ed. New York: Mc Graw-Hill Medical Publishing Division 2001: 1279-1304.
30. Hyun BH, Kwa D, Gabaldon H et al. Reactive plasmocytic lesions of the bone marrow. Am J Clin Pathol 1976; 65: 921-928.
31. Turesson I. Nucleolar size in benign and malignant plasma cell proliferation. Acta Med Scand 1975; 197: 7-14.
32. Smetana K, Gyorkey F, Gyorkey P et al. Ultrastructural studies on human myeloma plasmocytes. Cancer Res 1973; 33: 2300-2309.
33. Graham RC, Bernier GM. The bone marrow in multiple myeloma: correlation of plasma cell ultrastructure and clinical state. Medicine 1975; 54: 225-243.
34. Scudla V, Wiedermann B, Kodousek R et al. Significance of nucleo-cytoplasmic maturation asynchrony in multiple myeloma. Neoplasma 1986; 33: 483-491.
35. Rajkumar SV, Greipp PR. Plasma cells and immunoglobulins. In: Mehta J, Singhal S. Myeloma. London: Martin Dunitz 2002: 3-23.
36. Adam Z. Imunofenotyp buněk mnohočetného myelomu. Hemat Transf 1997; 7: 17-26.
37. Malpas JS, Bergsagel DE, Kyle RA et al. Myeloma biology and management. 3rd ed. Philadelphia: WB Saunders 2004.
38. Tricot G. Multiple myeloma and other plasma cell disorders. In: Hoffman R, Benz EJ, Shattil SJ et al. Hematology basic principles and practice. 3rd ed. New York: Churchill Livingstone 2000: 1398-1415.